ro 31-8220 has been researched along with Carcinogenesis in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
Excerpt | Relevance | Reference |
---|---|---|
"ErbB2 overexpression drives oncogenesis in 20-30% cases of breast cancer." | 1.40 | A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells. ( Ahmad, G; Bailey, TA; Band, H; Band, V; Bielecki, TA; George, M; Kelly, DL; Luan, H; Mohapatra, B; Natarajan, A; Raja, SM; Tom, E, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, TA | 1 |
Luan, H | 1 |
Tom, E | 1 |
Bielecki, TA | 1 |
Mohapatra, B | 1 |
Ahmad, G | 1 |
George, M | 1 |
Kelly, DL | 1 |
Natarajan, A | 1 |
Raja, SM | 1 |
Band, V | 1 |
Band, H | 1 |
1 other study available for ro 31-8220 and Carcinogenesis
Article | Year |
---|---|
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.
Topics: Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Carbazoles; Carcinogenesis; Cell Line, Tumor | 2014 |